 "Derivative strategies for Sun Pharma, Idea Cellular from Geojit BNP Paribas")
DERIVATIVE STRATEGIES
SUN PHARMA: BUY
TARGET: Rs 838
STOP LOSS: Rs 811
BUY SUNPHARMA FUTURES @ Rs 819, TARGET Rs 838, STOPLOSS OF Rs 811
[STOCHASTICS BUY + ABV 50 DMA + VOLUME JUMP]
IDEA CELLULAR: SELL
TARGET: Rs 103
STOP LOSS: Rs 114
SELL IDEA CELLULAR FUTURES @ Rs 110, TARGET Rs 103, STOPLOSS OF Rs 114
[MACD & STOCHASTICS SELL + BELOW MOVING AVERAGES + VOLUME JUMP]
Disclaimer: This report has been prepared by Geojit BNP Paribas Financial Services Limited (GBNPP), here in after referred to as GBNPP. GBNPP, a publicly listed company, is engaged in services of retail broking, credit, portfolio management and marketing investment products including mutual funds, life and general insurance and properties. Each recipient of this report should make such investigation as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this report (including the merits and risks involved). This document is not for public distribution and has been furnished to you solely for your information and must not be reproduced or redistributed to any other person. Persons into whose possession this document may come are required to observe these restrictions. Opinion expressed herein is our current opinion as of the date appearing on this report only. While we endeavor to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. Prospective investors and others are cautioned that any forward-looking statements are not predictions and may be subject to change without notice.
